MD1092G2 - Metodă de prognozare a evoluţiei bronşitei recidivante la copii - Google Patents

Metodă de prognozare a evoluţiei bronşitei recidivante la copii

Info

Publication number
MD1092G2
MD1092G2 MD98-0065A MD980065A MD1092G2 MD 1092 G2 MD1092 G2 MD 1092G2 MD 980065 A MD980065 A MD 980065A MD 1092 G2 MD1092 G2 MD 1092G2
Authority
MD
Moldova
Prior art keywords
bronchitis
evolution
anamnesis
remission
prognostication
Prior art date
Application number
MD98-0065A
Other languages
English (en)
Russian (ru)
Inventor
Svetlana Sciuca
Константин ЖУКОВСКИЙ
Original Assignee
Svetlana Sciuca
Константин ЖУКОВСКИЙ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Svetlana Sciuca, Константин ЖУКОВСКИЙ filed Critical Svetlana Sciuca
Priority to MD98-0065A priority Critical patent/MD1092G2/ro
Publication of MD1092G2 publication Critical patent/MD1092G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Invenţia se referă la medicină, în special la pulmonologia infantilă şi poate fi utilizată pentru pronosticul variantelor de evoluţie a bronşitei recidivante la copii.Metoda include relevarea din datele anamnestice a factorilor predispozanţi la dezvoltarea bronşitei cronice şi alergozelor respiratorii, inclusiv antecedentele ereditare şi factorul de fumat pasiv, aprecierea factorilor relevaţi prin valori numerice, efectuarea examenului general al sângelui în perioada de acutizare şi remisiune a bronşitei recidivante cu determinarea diferenţei numărului de eozinofile în aceste perioade ale maladiei şi calculul coeficienţilor de pronostic F0 şi F1 conform formulelor:F0 = -1,291×FP+3,236×NM+1,378×BC+4,637×AR+4,327×DA-2,909×AA+5,651×DB+2,824×AP++1,114×L1+1,535×L2-0,104×E+0,051×DE-16,435;F1 = -1,186×FP+3,254×NM+ 2,549×BC+ 3,471× ×AR+1,703×DA+0,492×AA+4,955×DB+1,966××AP+1,266×L1+1,740×L2-0,014×E+0,114×DE- 18,359,unde:FP - factorul de fumat pasiv;NM - factori nocivi ai microambianţei;BC - antecedente ereditare de bronşită cronică;AR - antecedente ereditare de alergoze respiratorii;DA - diateza alergică la vârstă fragedă;AA - alergie alimentară;DB - debutul bronşitei (vârsta);AP - antecedente perinatale;L1 - numărul de leucocite în perioada de acutizare a bronşitei;L2 - numărul de leucocite în perioada de remisiune;E - numărul de eozinofile în perioada de remisiune;DE - diferenţa numărului de eozinofile în perioadele de acutizare şi remisiune.În cazul când F1>F0 se prognozează o evoluţie a bronşitei în maladii bronhopulmonare cronice, iar în cazul când F0>F1 - o evoluţie favorabilă a bronşitei cu însănătoşire.Rezultatul tehnic constă în sporirea preciziei pronosticului.
MD98-0065A 1998-03-16 1998-03-16 Metodă de prognozare a evoluţiei bronşitei recidivante la copii MD1092G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD98-0065A MD1092G2 (ro) 1998-03-16 1998-03-16 Metodă de prognozare a evoluţiei bronşitei recidivante la copii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD98-0065A MD1092G2 (ro) 1998-03-16 1998-03-16 Metodă de prognozare a evoluţiei bronşitei recidivante la copii

Publications (1)

Publication Number Publication Date
MD1092G2 true MD1092G2 (ro) 1999-06-30

Family

ID=62129549

Family Applications (1)

Application Number Title Priority Date Filing Date
MD98-0065A MD1092G2 (ro) 1998-03-16 1998-03-16 Metodă de prognozare a evoluţiei bronşitei recidivante la copii

Country Status (1)

Country Link
MD (1) MD1092G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3181G2 (ro) * 2005-10-24 2007-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de pronosticare a riscului apariţiei infecţiilor septico-purulente nozocomiale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
М. Б., Киршин Г. И. Рецидивирующий бронхит у детей и подростков. Ленинград, 1984 г., с. 92-97 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3181G2 (ro) * 2005-10-24 2007-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de pronosticare a riscului apariţiei infecţiilor septico-purulente nozocomiale

Similar Documents

Publication Publication Date Title
Andersen et al. Formaldehyde: integrating dosimetry, cytotoxicity, and genomics to understand dose-dependent transitions for an endogenous compound
Mwaanga et al. Preliminary review of mine air pollution in Zambia
Quinn et al. Clinical correlates of steady‐state oxyhaemoglobin desaturation in children who have sickle cell disease
Marsh et al. Thymidine catabolism by normal and leukemic human leukocytes
Sureda et al. Relation between oxidative stress markers and antioxidant endogenous defences during exhaustive exercise
Liu et al. Serum creatinine determined by Jaffe, enzymatic method, and isotope dilution‐liquid chromatography‐mass spectrometry in patients under hemodialysis
Järv et al. Structure‐Activity Relationships in Acetylcholinesterase Reactions: Hydrolysis of Non‐ionic Acetic Esters
Hussain et al. Inhibition of prolyl hydroxylase by poly (ADP-ribose) and phosphoribosyl-AMP: Possible role of ADP-ribosylation in intracellular prolyl hydroxylase regulation
WO2004079508A3 (en) Method and system for monitoring transactions
Wang et al. Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease
Wilbrandt et al. The kinetics of glucose transport through the human red cell membrane
MD1092G2 (ro) Metodă de prognozare a evoluţiei bronşitei recidivante la copii
Pattison-Granberg et al. Regulation of cation-coupled high-affinity phosphate uptake in the yeast Saccharomyces cerevisiae
Gencer et al. Prolidase activity dysregulation and its correlation with oxidative–antioxidative status in chronic obstructive pulmonary disease
Postlethwait et al. Pulmonary disposition of inhaled NO2-nitrogen in isolated rat lungs.
Audi et al. Pulmonary reduction of an intravascular redox polymer
Weber et al. Clinical, demographic and oxidative profile of patients with COVID-19 and disease severity
Duda-Seiman et al. QSAR modelling of anti-HIV activity with HEPT derivatives
Mutimer et al. Rate and determinants of antiviral treatment initiation for patients with HBeAg‐negative chronic hepatitis B
Braun Approaches to the top advances in analytical chemistry, 1935–1985
LI et al. Prognostic Value and Immune Infiltration of Anoikis-related LncRNAs in Lung Adenocarcinoma
Qing et al. Research of UL54‐specific siRNA on herpes simplex virus type II replication
Cardoso et al. Ammonia and urea metabolism in acute liver failure: A multicentre cohort study
Leonard et al. Cigarette Smoking Increases Human Vitamin E Requirements as Estimated by Plasma Deuterium‐Labeled CEHC
Çankaya et al. Can keto/amino acids reduce oxidative stress in peritoneal dialysis patients with hypoalbuminemia?